Abrupt Benzodiazepine Discontinuation, Seizure Risk, and Emergency Care¶

Running out of a daily benzodiazepine prescription, having a prescriber abruptly terminate refills, or attempting to quit high-dose prescription or street benzodiazepines (alprazolam / Xanax, clonazepam / Klonopin, lorazepam / Ativan, diazepam / Valium, temazepam, or illicitly pressed bromazolam) "cold turkey" at home is an acute neurological emergency. Like alcohol, benzodiazepines are positive allosteric modulators of the brain's inhibitory \(\text{GABA}_\text{A}\) chloride ion channels. When taken daily for more than 3 to 6 weeks, the central nervous system physically downregulates and internalizes its natural GABA receptors while upregulating excitatory glutamate (NMDA and AMPA) receptors and voltage-gated calcium channels.

If the benzodiazepine is suddenly cut off, or even reduced too rapidly by 50 percent, the brain loses its chemical inhibitory brake while excitatory glutamate fires unchecked. Depending on the drug's elimination half-life, within 12 hours to 10 days a person can progress from intense rebound panic, burning skin paresthesias, muscle fasciculations, and depersonalization into sudden generalized tonic-clonic convulsions, status epilepticus, catatonia, and withdrawal delirium. Even worse, traditional 5-to-7-day inpatient detox programs that rapidly strip patients off years of benzodiazepines frequently trigger severe Protracted Withdrawal Syndrome (BIND: Benzodiazepine-Induced Neurological Dysfunction) and acute suicidal akathisia. Knowing when to seek immediate Hospital Emergency Department stabilization, how to calculate Diazepam (Valium) Equivalence, and how evidence-based Ashton Manual and ASAM slow hyperbolic tapers work protects your brain and your life.

E hana i kēia i kēia manawa¶

1. Call your local emergency number or go to the nearest Hospital Emergency Department immediately if someone who has stopped or cut down on benzodiazepines has a seizure, hallucinates, becomes confused, or develops uncontrollable muscle jerking. Dial 911 in the United States and Canada, 112 across the European Union, 999 in the United Kingdom, or check our helu pilikia directory.
2. Never stop daily benzodiazepines (or Z-drugs like zolpidem/Ambien, eszopiclone, or zopiclone) abruptly "cold turkey." Even if you have been taking a standard therapeutic dose prescribed by a doctor for panic or insomnia for several months, stopping all at once can trigger a grand mal seizure without warning.
3. If you have run out of your prescribed benzodiazepine on a weekend, lost your medication, or had a clinic abruptly close, go to an urgent care clinic or Hospital Emergency Department with your labeled prescription bottle and pharmacy printout. Under US Food and Drug Administration (FDA) Boxed Warnings and UK/international clinical guidelines, abrupt discontinuation of dependent benzodiazepine patients is medically contraindicated. Request an emergency stabilization bridge prescription or cross-taper referral to prevent withdrawal seizures.
4. Watch closely for "pre-seizure" neurological warning signs. If you or a loved one develops violent startle reflexes (myoclonic jerks when a door closes), visible muscle twitching in the face or calves, metallic taste in the mouth, extreme sensitivity to light and sound, or a feeling that the floor is tilting, the seizure threshold is critically low. Go to the hospital emergency room immediately.
5. Protect a seizing person from head trauma and roll them into the Recovery Position. Clear hard objects away, place a folded pillow or coat under the head, time the seizure, never put anything inside the mouth, and roll the person onto their side once convulsions stop. See our hopu i ke kokua mua alakai.
6. Screen actively for acute Akathisia and suicidal crisis. Abrupt benzodiazepine withdrawal can cause akathisia, an agonizing inner neurological restlessness and skin-crawling terror that drives impulsive self-harm. Never leave someone in acute benzodiazepine withdrawal alone; if suicidal thoughts arise, go to the hospital ED or call 988 (US/Canada Suicide & Crisis Lifeline) or 111 / 999 (UK).

Decision Tree: Triaging Abrupt Benzodiazepine Interruption¶

Use this clinical flowchart when a prescription runs out, a dose is missed, or someone attempts to stop benzodiazepines.

flowchart TD
    A["Abrupt Stop or Rapid Drop in Daily Benzodiazepine Use (>3 to 4 Weeks Duration)"] --> B{"Are Emergency Neurological Signs Present Right Now?"}
    B -->|"Seizure, myoclonic jerking, psychosis/hallucinations, confusion, pulse >115 bpm, or suicidal akathisia"| C["CRITICAL NEUROLOGICAL EMERGENCY: Call 911 / 112 / 999 Immediately for Hospital ED IV/Oral Benzodiazepine Stabilization"]
    B -->|"Patient is alert and oriented, but prescription has run out or withdrawal anxiety/tremor is starting"| D{"What is the potency, dose, and half-life of the benzodiazepine?"}
    D -->|"High-potency short-acting (Alprazolam/Xanax, Lorazepam, Triazolam, street Bromazolam) OR High Daily Dose"| E["KA HOʻOPIʻI O KA HOPE (Hoʻomaka 12 a i 48 mau hola): E hele i ka Halemai ED a i ʻole Kauka Urgent i kēia lā me Rx Bottle no Bridge / Cross-Taper"]
    D -->|"Long-acting therapeutic dose (Diazepam/Valium, Chlordiazepoxide, Clonazepam) within first 24 hours"| F["PILIKIA HOPE I KA HOPE (La 3 a hiki i ka lā 10): E hoʻokaʻaʻike koke i ke kauka / lāʻau lapaʻau kuhikuhi e hoʻomaka hou a hoʻolālā i ka 5-10% hyperbolic taper lohi."]
    C --> G["Hospital Protocol: Re-establish GABA-A receptor occupancy (Diazepam/Lorazepam/Phenobarbital) and transition to slow outpatient taper"]
    E --> G

Part 1: Why Short-Acting vs. Long-Acting Benzodiazepines Fail on Different Timelines¶

Unlike alcohol, which clears from the bloodstream in hours and always triggers withdrawal on a predictable 6-to-96-hour clock, benzodiazepines vary by more than 10-fold in their elimination half-lives. As a result, a person stopping alprazolam (Xanax) crashes into acute withdrawal seizures within 18 to 36 hours, whereas a person stopping diazepam (Valium) or clonazepam (Klonopin) may feel completely normal for the first 3 or 4 days and then suddenly suffer a grand mal seizure on Day 5, Day 7, or Day 10.

Pharmacokinetic & Equivalence Table: Major Benzodiazepines and Z-Drugs¶

(Based on the Ashton Manual, American Society of Addiction Medicine / ASAM 2025 Clinical Practice Guideline, and British National Formulary; approximate oral equivalence to 10 mg of Diazepam / Valium is shown so patients and families understand just how strong "1 milligram" of a high-potency benzodiazepine really is.)

Mahele 2: E ʻike ana i nā ʻāpana ʻokoʻa 3 o ka haʻalele ʻana o Benzodiazepine.¶

No ka mea, ua māhele ʻia nā mea loaʻa \(\text{GABA}_\text{A}\) ʻaʻole wale i loko o ke kikowaena o ka naʻau o ka lolo (ka amygdala), akā, i loko o ka ʻōpū kaʻa, visual/auditory cortex, spinal cord, a me ka ʻōpū (enteric nervous system), hiki i ka wehe ʻana o benzodiazepine i ** mau hōʻailona kino a me ka naʻau ** i ʻike pinepine ʻia e nā poʻe maʻi a me nā limahana lumi pilikia. vertigo, a i ʻole psychosis mua:

1. Cluster A: Excitatory Sensory & Perceptual Distortion (Pre-Seizure Warning Signs)¶

• Hyperacusis a me Photophobia: E ʻeha nā leo kamaʻilio maʻamau, nā mea ʻai kala, a i ʻole nā ​​kukui o loko, e hou ana i nā pepeiao a me nā maka.
• Tinnitus a me Metallic Taste: Leo nui, kani leo kiʻekiʻe a uwo paha i loko o nā pepeiao i hui pū ʻia me kahi ʻono ʻē aʻe a i ʻole kemika ma ke alelo.
• Paresthesias a me "Benzo Belly": Puhi, ʻuʻuku, hoʻopuʻi uila ("brain zaps"), ʻeha nā pine-a-needles ma nā wēlau, a me ka ʻeha nui o ka ʻōpū a i ʻole gastroparesis.
• Derealization and Depersonalization: He mea weliweli e like me ka moeʻuhane ʻo ka lumi a puni he palahalaha, ʻelua-dimensional, a i ʻole hana ʻia (derealization), a i ʻole ka hemo ʻana o ke kanaka mai kona kino ponoʻī (depersonalization), i hele pinepine ʻia me ka ʻike ʻike ʻana i nā paia a i ʻole nā ​​​​papae e ʻoluʻolu.

2. Cluster B: Neuromuscular & Autonomic Hyperactivity¶

• Myoclonus a me Fasciculations: ʻO ka ʻili a i ʻole ka ʻuʻu ʻana e like me ka ilo ma lalo o ka ʻili o ka lihilihi, nā manamana nui, nā keiki bipi, a me nā ʻūhā, e holomua ana i ka ** ʻōpuʻu kino holoʻokoʻa (myoclonic jerks)** e hōʻike ana e kokoke ana ka ʻōpū kaʻa kaʻa i ka paepae convulsive seizure.
• Akathisia (The Highest Suicide-Risk Symptom): ʻAʻole wale "ka hopohopo," akathisia he mea hiki ʻole ke hoʻomaha ʻia, hoʻoulu ʻia i loko o ke kino kahi i manaʻo ai ka mea maʻi ua hoʻopili ʻia ko lākou ʻōnaehana nerve i loko o kahi kumu uila, e koi ana iā lākou e holo i ka papahele no nā hola he hiki ʻole ke noho a moe i lalo no 10 kekona. Pono e ʻike koke ʻia ʻo Akathisia ma ke ʻano he hopena ʻaoʻao o ka wehe ʻana i ka lāʻau lapaʻau ma mua o ka "hana ʻana."
• Autonomic Storm: Hoʻomaha ʻana o ka naʻau ma luna o 100 a 130 paʻi i kēlā me kēia minuke, piʻi ka piʻi ʻana o ke koko, hoʻomaloʻo ʻana i ka hou o ka pō, nā haumāna ākea, a me ka insomnia hohonu (0 mau hola hiamoe no 3 a 5 mau pō.

3. Cluster C: Nā ʻĀpana Neurological Hoʻoweliweli (E kelepona iā 911 / 112 / 999 koke)¶

• Generalized Tonic-Clonic Seizures & Status Epilepticus: Hiki ke hana ma ke ano he grand mal convulsion a i ʻole ka hoʻihoʻi hou ʻana i hope me ka ʻike ʻole ma waena o lākou (status epilepticus), ka mea e hōʻeha mau ai ka lolo hypoxic a make paha inā ʻaʻole i hoʻopau ʻia me nā lāʻau GABAergic pilikia.
• ** Benzodiazepine Withdrawal Delirium & Psychosis:** ʻO nā hiʻohiʻona ʻike, auditory, a i ʻole paranoid hallucinations i hui pū ʻia me ka disorientation, huikau, a me ke kuni (like clinical like me Delirium Tremens).
• Withdrawal Catatonia: He mokuʻāina kakaʻikahi a koʻikoʻi kahi e lilo ai ka mea maʻi e haʻalele ana i ka leo, ʻoʻoleʻa, nānā pono ʻole i ka lewa, a hoʻōki i ka ʻai ʻana a i ʻole ka inu ʻana, hiki ke hoʻohuli ʻia me ka intravenous a i ʻole ka sublingual lorazepam.

Mahele 3: He aha kāu e hana ai inā pau ʻoe i nā lāʻau lapaʻau a ʻoki koke ʻia paha¶

He mau miliona o ka poʻe maʻi e lawe i nā benzodiazepine i kauoha ʻia e like me ke kuhikuhi ʻana no nā makahiki, e kū wale ana i kahi pilikia hikiwawe i ka wā ** i hoʻomaha ai kā lākou kauka lōʻihi, neʻe lākou i kahi mokuʻāina hou, ke kū nei kahi lāʻau lapaʻau i kahi backorder lako, ua ʻaihue ʻia kā lākou ʻōmole pila i ka wā e hele ana, a i ʻole kahi mea lawelawe hou e hōʻole e hoʻomau i kā lākou ʻōlelo kuhikuhi.**

E hāhai i kēia 4-Step Emergency Stabilization Action Plan ma mua o ka piʻi ʻana o ka haʻalele ʻana:

KaʻAnuʻu Hana 1: E nānā inā hiki i kāu lāʻau lapaʻau ke hoʻopuka i kahi "Emergency 72-Hour Bridge Supply"¶

Inā loaʻa iā ʻoe kahi moʻolelo kuhikuhi i hoʻopaʻa ʻia ma kahi kaulahao lāʻau kūʻai kūʻai a ʻaʻole hiki ke loaʻa kāu kauka i ka hopena pule a i ʻole hoʻomaha: - E lawe mai i kāu omole i kapa ʻia i kēia manawa (no ka mea, ʻo benzodiazepines ka Schedule IV controlled substances ma US a me nā lāʻau lapaʻau i hoʻopaʻa ʻia ma UK/Kanada/EU, ʻoi aku ka koʻikoʻi o nā kānāwai ma mua o nā lāʻau paʻi koko, *akā naʻe. withdrawal seizures). - Ma United Kingdom, e kelepona koke iā NHS 111 no ke noi ʻana i ka loiloi lāʻau hoʻoponopono hou ʻana i ka lāʻau ma o ka lawelawe GP ma waho o nā hola.

KaʻAnuʻu 2: Pehea e hōʻike ai i kahi Keʻena ʻOihana Hoʻomaʻamaʻa (Exact Patient Script)¶

Inā ʻaʻole hiki iā ʻoe ke kiʻi aku i kahi mea kuhikuhi, ʻaʻole i pau nā lāʻau, a ke hoʻomaka nei e ʻike i ka haʻalulu, ka puʻuwai holo, ka ʻiʻo ʻana o ka ʻiʻo, a i ʻole ka hoʻihoʻi hou ʻana o ka makaʻu, **e hele i kahi keʻena ʻoihana pilikia ma mua o kahi hale kūʻai kūʻai hele wāwae ** (he nui nā keʻena mālama koʻikoʻi kūʻai kūʻai i nā kulekele hui e pāpā ana i ke kuhikuhi ʻana i ka lāʻau lapaʻau IV).

No ka hōʻole ʻana i ka hoʻopaʻa ʻia ʻana ma ka hoʻāʻo ʻana ma ke ʻano he "ʻimi lāʻau," ** lawe mai i kāu mau ʻōmole kuhikuhi kino, ka moʻolelo o ka lāʻau lapaʻau e hōʻike ana i kāu hoʻopiha piha ʻana i kēlā me kēia mahina, a me ka ID kiʻi **, a e hoʻohana i kēia palapala kamaʻilio maʻemaʻe.

• "Ua lawe au i [ka lāʻau pololei a me ka lāʻau milligram i kēlā me kēia lā, e like me Clonazepam 1 mg ʻelua i kēlā me kēia lā] mau no [X mahina/makahiki] e like me ka mea i kuhikuhi ʻia e Kauka [Name]. Ua hoʻopau ʻia kaʻu lako no ka mea [ua hoʻomaha ke kauka / nalowale i ka huakaʻi / pani ʻia ke keʻena kino], a ʻo kaʻu dosis hope loa he [X] mau hola i hala aku nei. ʻAʻole au e noi ana i ka lāʻau lapaʻau no ka wā lōʻihi: Ke noi nei au i ka hoʻopaʻa ʻana i ka lāʻau lapaʻau no ka pale ʻana i ka hopu ʻana i ka benzodiazepine a me kahi alahaka palekana a hiki i koʻu ʻike ʻana i kaʻu kauka maʻi maʻi hou i ka [La]."*

KaʻAnuʻu Hana 3: No ke aha he 5-Day "Rapid Detox" Center he pōʻino no ka lōʻihi o ka hilinaʻi Benzodiazepine¶

He ʻōlelo aʻo koʻikoʻi koʻikoʻi i kākoʻo ʻia e ka 2020 FDA Benzodiazepine Boxed Warning, ka 2025 ASAM Joint Clinical Practice Guideline on Benzodiazepine Tapering, a me ka British National Formulary: - Mai hoʻopaʻa inoa i ka mea maʻi benzodiazepine lōʻihi i kēlā me kēia lā i loko o kahi papahana hoʻomaʻemaʻe anu-turkey wikiwiki no 5-a-7 mau lā ke ʻole lākou i loko o kahi pilikia olakino e hoʻoweliweli i ke ola e koi ana i ka hoʻololi ʻana i ka maʻi phenobarbital/anticonvulsant. - ʻAʻole like me ka opioids a i ʻole ka waiʻona, kahi hiki ke hoʻopau ʻia ka detox kino kino i loko o 5 a 10 mau lā, \(\text{GABA}_\text{A}\) nā subunits receptor i hoʻololi ʻia e nā mahina a i ʻole mau makahiki o nā benzodiazepine i kēlā me kēia lā e lawe i ** mau mahina (ʻaʻole nā ​​lā)** e kākau kino i nā protein receptor hou a hoʻi i ka papa kuhikuhi. - ʻO ka wehe ʻana i ka mea maʻi i 2 mau makahiki o Klonopin a i ʻole Xanax i nā lā 5 ma kahi hale detox pāʻoihana e hoʻouna pinepine iā lākou i ka home ma ka lā 6 pono i ka wā e ʻike ʻia ai nā metabolites lōʻihi, e hopena i ka ** ma waho o ka hale maʻi nui ma ka lā 8** a i ʻole mau mahina o ka hoʻonāwaliwali ** Protracted Withdrawal Syndrome (BIND)**.

Mahele 4: Pehea e hana ai ka Benzodiazepine Tapering i nā hōʻike (The Ashton & ASAM Method)¶

Ke hoʻopaʻa ʻia ka pilikia hoʻihoʻi ʻana i loko o ka Emergency Department a i ʻole ke keʻena maʻi maʻi ma o ka hoʻihoʻi ʻana i kahi maʻi maʻamau, ʻo ka hoʻopau palekana ʻana e hahai ** ʻekolu mau kumu lapaʻau e pili ana i nā hōʻikeʻike** i paionia e Professor C. Heather Ashton (The Ashton Manual) a i hoʻopaʻa ʻia e ka American Society of Addiction Medicine (ASAM): a me NICE Medicine Medicine (ASAM):

1. Kumu 1: E hoʻopaʻa a hoʻopaʻa i ke keʻa mai ka Diazepam hana pōkole a hiki i ka lōʻihi.¶

ʻO ka hoʻāʻo ʻana e hoʻopaʻa pololei i kahi benzodiazepine pōkole e like me alprazolam (Xanax) he mea paʻakikī loa no ka mea, ʻo ka hapalua o ke ola he 6-a-12-hola e hāʻule ai ke kiʻekiʻe o ke koko o ka mea maʻi i ʻehā manawa i ka lā (inter-dose withdrawal), e hana ana i nā ʻino ʻino liʻiliʻi ma waena o kēlā me kēia pila. - Eia kekahi, hele mai ʻo Xanax a me Ativan i loko o nā papa liʻiliʻi liʻiliʻi (0.5 mg, 1 mg, 2 mg) ʻaʻole hiki ke ʻoki maʻalahi i nā hōʻemi liʻiliʻi 5 pakeneka. - No laila, hana pinepine nā kauka i kahi ** hoʻololi i kēlā me kēia ʻanuʻu (cross-taper)** i ka nui like o long-acting Diazepam (Valium) (a i ʻole hoʻohana i ka wai micro-dosing / hui pū ʻana o clonazepam a i ʻole lorazepam). No ka mea, he 100-a-200-hour active metabolite half-life ka diazepam a ua hana ʻia i loko o 2-milligram, 5-milligram, a me 10-milligram scored papa (a me 1 mg/mL hoʻoheheʻe wai waha), hana ia i ka "coo cushion" maʻemaʻe a paʻa a hiki ke hoʻemi ʻole ʻia he 0.5-miligram.

2. Kumu 2: Ho'emi 'ia "Hyperbolic" lohi, ho'omanawanui (5% a 10% i kela a me keia 2 a 4 pule)¶

• Mai ʻoki ʻia e kahi ʻāpana nui paʻa (e like me "ʻoki ʻia 25% i kēlā me kēia pule"). Hōʻike nā haʻawina noho ʻana o ka mea hoʻokipa PET-scan e pili ana ka \(\text{GABA}_\text{A}\) i kahi ** hyperbolic curve**: ʻo ka 2 milligrams hope loa o ka diazepam e noho ana i ka hapa nui o ka 10 milligrams mua.
• Manaʻo nā alakaʻi lapaʻau maʻamau e hōʻemi i ka ** kau i kēia manawa ma ka 5 pākēneka i ka 10 pākēneka i kēlā me kēia 2 a hiki i 4 pule**, a e hoʻolōʻihi aʻe i ka wā o ka hapaha hope o ka taper, ʻoiai ** e hoʻopaʻa paʻa i ka dosis ** no ʻelua mau pule i kēlā me kēia manawa ke ʻā aʻe nā hōʻailona hemo. ʻO ka mea maʻi, ʻaʻole kahi kalena paʻa, hoʻonohonoho i ka wikiwiki o ka taper.

3. Laʻana Hoʻololi i kēlā me kēia pae a me ke kiʻi Hyperbolic Taper¶

No ka hoʻomaopopo ʻana i ke ʻano o ka hoʻololi palekana ʻana o ke kauka lapaʻau a i ʻole psychiatrist i ka mea maʻi mai kahi benzodiazepine pōkole me ka ʻole o ka hoʻomaka ʻana o ka wehe ʻana a i ʻole ka hopu ʻana, e nānā i ke ʻano o ka Ashton Cross-Taper maʻamau i hoʻololi i ka 1.5 mg i kēlā me kēia lā o Alprazolam (Xanax) (lawe ʻia he 0.5 mg. e like me 30 mg o Diazepam / Valium) ma ka diazepam ma mua o ka hoʻoemi ʻana:

4. Ka Lehulehu Ki'eki'e Kūikawā: 'Okahiko, Hape, a me nā mea ho'omaha.¶

Ke kū nei kekahi poʻe i nā pilikia olakino kūikawā i ka wā o ka hoʻopau ʻana i ka benzodiazepine a koi aku i ke kauka lapaʻau kūikawā:

1. Ka poʻe ʻelemakule (65 makahiki a ʻoi aku paha):
   • Me ka ulu ʻana o ka makahiki, lohi ka hana enzyme ate cytochrome P450 a piʻi ka momona o ke kino, e hoʻolōʻihi i ka hapalua o ke ola o ka diazepam a me chlordiazepoxide mai 40 mau hola a hiki i ** ma luna o 150 a 200 mau hola **.
   • I ka poʻe ʻelemakule, ʻaʻole hōʻike pinepine ʻia ka wehe ʻana o ka benzodiazepine ma ke ʻano he "panic" maʻamau, akā ma ke ʻano he ** ʻano delirium keʻano o ka haukapila, hāʻule koke, hiʻohiʻona ʻike, a i ʻole huikau e like me ka hahau ʻana** e hoʻomaka ana i 5 a 10 mau lā ma hope o ka hoʻololi ʻana. ʻO ka mea ʻē aʻe, i ka wā e hoʻopaʻa ʻia ai ke kanaka ʻelemakule, makemake pinepine nā kauka i ka haʻahaʻa haʻahaʻa lorazepam a i ʻole oxazepam (a i ʻole ka hoʻemi pono ʻana i nā doses diazepam) e pale aku i ka hoʻomaha ʻana i ke ao a hāʻule ka haʻi wāwae.
2. Hoʻihoʻi ʻana i ka hāpai ʻana a me ka neonatal:
   • ʻO ka hoʻōki koke ʻana i ka benzodiazepine i kēlā me kēia lā i ka wā hāpai ʻaʻole loa i hōʻole ʻia no ka mea ʻo ka hoʻihoʻi ʻana o ka makuahine ke kumu o ** hypoxia fetal, abruption placental, a i ʻole ka hāʻule ʻana o ka hānau hānau mua**. Pono e mālama ʻia nā poʻe maʻi hāpai e ka psychiatrist perinatal a me ka obstetrician me ka hoʻohana ʻana i ka haʻahaʻa haʻahaʻa haʻahaʻa haʻahaʻa a i ʻole ka lohi, nānā ʻia ka trimester taper.
3. Hoʻohana i ka waiʻona a i ʻole ka hoʻohana ʻana i ka opioid:
   • Inā hilinaʻi ka mea maʻi i nā opioids a me benzodiazepines, ʻo ka 2020 FDA Guidance a me ASAM Guidelines ʻaʻole pono e ʻoki koke nā mea kuhikuhi ** i ka palapala kauoha benzodiazepine lōʻihi o ka mea maʻi ma muli wale nō o ka hoʻomaka ʻana o ka mea maʻi i Buprenorphine (Suboxone) a i ʻole Methadonebcess a methadoneb. hopu a hoʻihoʻi i nā maʻi i nā lāʻau lapaʻau fentanyl/alanui.

5. Kumu 3: Nā lāʻau e hōʻalo i ka wā o ka haʻalele ʻana o Benzodiazepine¶

Pono e ʻalo loa i kekahi mau lāʻau lapaʻau maʻamau i ka wā o ka hoʻihoʻi ʻana i ka benzodiazepine a i ʻole ka hoʻoemi ʻana no ka mea e kūʻē pololei ana lākou i ka \(\text{GABA}_\text{A}\) a i ʻole e hoʻohaʻahaʻa i ka paepae hopu:

Nīnau pinepine¶

Nānā ʻia nā kumu¶

• American Society of Addiction Medicine (ASAM) & ʻeiwa mau hui lapaʻau hoa hana (2025): Joint Clinical Practice Guideline on Benzodiazepine Tapering (Risk assessment, hyperbolic dose reduction schedules, cross-tapering to long-acting formulations, and inpatient vs. outpatient care).
• United States Food and Drug Administration (FDA): FDA Drug Safety Communication: Boxed Warning Updated to Improve Safe Use of Benzodiazepine Drug Class (Nā pilikia o ka hilina'i kino, ho'opa'i ho'i i ke ola mai ka ho'opau koke 'ana, a me ka ma'i ho'one'e lō'ihi).
• Ashton, C. Heather (Newcastle University Institute of Neuroscience, United Kingdom): Benzodiazepines: How They Work and How to Withdraw (The Ashton Manual), e uhi ana i nā papa helu kaulike diazepam, nā protocols substitution lohi, a me ka hoʻoponopono kino o nā hōʻailona withdrawal acute and protracted withdrawal.
• National Institute for Health and Care Excellence (NICE) and British National Formulary (BNF, United Kingdom): Medicines Associated with Dependence or Withdrawal Symptoms: Safe Prescribing and Withdrawal Management for Adults (NG214).
• World Health Organization (WHO): Nā Kūlana Kauka no ka Hoʻoponopono Hoʻihoʻi ʻana a me ka Lapaʻau ʻana i ka hilinaʻi ʻana i ka lāʻau lapaʻau (Sedative-hypnotic withdrawal seizure prophylaxis and delirium management).

Nā alakaʻi pili¶

• Ka hoʻohana ʻana i ka lāʻau a me ka hoʻohui ʻana i ka lāʻau: alakaʻi kōkua pilikia
• ʻO ka wehe ʻana i ka waiʻona koʻikoʻi, Delirium Tremens (DTs), a me ka hoʻāʻo detox lāʻau
• Ma hope o ka hoʻomanawanui hou ʻana i ka overdose pilikia, xylazine, a me naloxone redosing
• Kākoʻo ʻana i kekahi lālā o ka ʻohana me ka addiction
• Hoʻopaʻa i ke kōkua mua
• Hoʻouka weliweli
• Pilikia ola kino
• Helu pilikia